-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $202

Benzinga·05/22/2026 15:52:44
Listen to the news
UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $180 to $202.